Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Placebo Controlled Phase II Trial of Allisartan
ChiCTR-TRC-10000886Phase 2Completed
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in essential hypertension comparing Allisartan Isoproxil 240 mg with Placebo (2 arms). Primary endpoint: Change in seated diastolic blood pressure from baseline to Week 8. Started Jul 2009; status: completed.
02
Drugs
allisartan isoproxil
03
Conditions
essential hypertension
Beyond the preview
Go deeper on ChiCTR-TRC-10000886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000886.